CAS 2206825-87-6

Fórmula: C25H27N5O5

InChI: InChI=1S/C25H27N5O5/c1-35-19-11-9-18(10-12-19)30-23-20(22(28-30)24(26)33)13-15-29(25(23)34)17-7-5-16(6-8-17)27-14-3-2-4-21(31)32/h5-12,27H,2-4,13-15H2,1H3,(H2,26,33)(H,31,32)

Clave InChI: JYXZVSMVCZWUPI-UHFFFAOYSA-N

SMILES: COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)NCCCCC(=O)O)C(=N2)C(=O)N

5-((4-(3-Carbamoyl-1-(4-methoxyphenyl)-7-oxo-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-6(7H)-yl)phenyl)amino)pentanoic acid

CAS: 2206825-87-6

Pureza: 97%

Ref: IN-DA01X7GQ

5-((4-(3-Carbamoyl-1-(4-methoxyphenyl)-7-oxo-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-6(7H)-yl)phenyl)amino)pentanoic acid

CAS: 2206825-87-6

5-((4-(3-Carbamoyl-1-(4-methoxyphenyl)-7-oxo-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-6(7H)-yl)phenyl)amino)pentanoic acid

Fórmula: C₂₅H₂₇N₅O₅

Pureza: 97%

Peso molecular: 477.52

Ref: 54-OR1074245

Apixaban Amino Acid Impurity

CAS: 2206825-87-6

Fórmula: C₂₅H₂₇N₅O₅

Forma y color: Pale Yellow Solid

Peso molecular: 477.52

Ref: 4Z-A-10221

5-[[4-[3-(Aminocarbonyl)-1,4,5,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6H-pyrazolo[3,4-c]pyridin-6-yl]phenyl]amino]pentanoic Acid

CAS: 2206825-87-6

Forma y color: Neat

Ref: 86-MM3754.04

5-((4-(3-Carbamoyl-1-(4-methoxyphenyl)-7-oxo-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-6(7H)-yl)phenyl)amino)pentanoic acid

CAS: 2206825-87-6

5-((4-(3-Carbamoyl-1-(4-methoxyphenyl)-7-oxo-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-6(7H)-yl)phenyl)amino)pentanoic acid

Fórmula: C₂₅H₂₇N₅O₅

Pureza: 97%

Peso molecular: 477.51

Ref: IN-DG01251982

Apixaban Amino Acid Impurity

CAS: 2206825-87-6

Fórmula: C₂₅H₂₇N₅O₅

Peso molecular: 477.52

Ref: ST-EA-CP-A3009

5-[[4-[3-(Aminocarbonyl)-1,4,5,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6H-pyrazolo[3,4-c]pyridin-6-yl]phenyl]amino]pentanoic Acid

CAS: 2206825-87-6

Applications Apixaban Open chain Acid Is an open ring impurity of Apixaban (A726700). Apixaben is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation.
References Luettgen, J.M. et al.: J. Enz. Inhib. Med. Chem., 26, 514 (2011); Glanis, T. et al.: J. Thromb. Thrombol., 31, 310 (2011); barrett, Y.C. et al.: Thromb. Haemos., 105, 181 (2011);

Fórmula: C₂₅H₂₇N₅O₅

Forma y color: Neat

Peso molecular: 477.51

Ref: TR-A875620